Annual Retained Earnings
-$80.13 M
+$17.15 M+17.63%
December 31, 2023
Summary
- As of February 12, 2025, ANIP annual retained earnings is -$80.13 million, with the most recent change of +$17.15 million (+17.63%) on December 31, 2023.
- During the last 3 years, ANIP annual retained earnings has fallen by -$75.16 million (-1511.67%).
- ANIP annual retained earnings is now -555.71% below its all-time high of $17.58 million, reached on December 31, 2019.
Performance
ANIP Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$89.60 M
-$24.57 M-37.79%
September 30, 2024
Summary
- As of February 12, 2025, ANIP quarterly retained earnings is -$89.60 million, with the most recent change of -$24.57 million (-37.79%) on September 30, 2024.
- Over the past year, ANIP quarterly retained earnings has dropped by -$8.72 million (-10.78%).
- ANIP quarterly retained earnings is now -499.65% below its all-time high of $22.42 million, reached on September 30, 2019.
Performance
ANIP Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ANIP Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.6% | -10.8% |
| 3 y3 years | -1511.7% | +6.9% |
| 5 y5 years | -797.5% | -948.0% |
ANIP Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -67.8% | +17.6% | -87.6% | +7.9% |
| 5 y | 5-year | -555.7% | +17.6% | -609.5% | +7.9% |
| alltime | all time | -555.7% | +67.3% | -499.6% | +63.8% |
ANI Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$89.60 M(+37.8%) |
| Jun 2024 | - | -$65.03 M(+4.3%) |
| Mar 2024 | - | -$62.33 M(-22.2%) |
| Dec 2023 | -$80.13 M(-17.6%) | -$80.13 M(-0.9%) |
| Sep 2023 | - | -$80.88 M(-10.5%) |
| Jun 2023 | - | -$90.41 M(-6.1%) |
| Mar 2023 | - | -$96.25 M(-1.1%) |
| Dec 2022 | -$97.29 M(+103.7%) | -$97.29 M(+5.0%) |
| Sep 2022 | - | -$92.64 M(+10.8%) |
| Jun 2022 | - | -$83.63 M(+22.4%) |
| Mar 2022 | - | -$68.30 M(+43.0%) |
| Dec 2021 | -$47.77 M(+860.7%) | -$47.77 M(+103.8%) |
| Sep 2021 | - | -$23.44 M(+23.4%) |
| Jun 2021 | - | -$18.99 M(+288.7%) |
| Mar 2021 | - | -$4.89 M(-1.7%) |
| Dec 2020 | -$4.97 M(-128.3%) | -$4.97 M(+271.9%) |
| Sep 2020 | - | -$1.34 M(-24.5%) |
| Jun 2020 | - | -$1.77 M(-116.8%) |
| Mar 2020 | - | $10.56 M(-39.9%) |
| Dec 2019 | $17.58 M(+53.1%) | $17.58 M(-21.6%) |
| Sep 2019 | - | $22.42 M(+21.0%) |
| Jun 2019 | - | $18.52 M(+55.2%) |
| Mar 2019 | - | $11.94 M(+3.9%) |
| Dec 2018 | $11.49 M(-386.8%) | $11.49 M(+89.6%) |
| Sep 2018 | - | $6.06 M(+493.3%) |
| Jun 2018 | - | $1.02 M(-158.1%) |
| Mar 2018 | - | -$1.76 M(-56.2%) |
| Dec 2017 | -$4.01 M(+37.4%) | -$4.01 M(-171.2%) |
| Sep 2017 | - | $5.62 M(+522.7%) |
| Jun 2017 | - | $903.00 K(-150.8%) |
| Mar 2017 | - | -$1.78 M(-39.0%) |
| Dec 2016 | -$2.92 M(-33.0%) | -$2.92 M(+58.8%) |
| Sep 2016 | - | -$1.84 M(-58.1%) |
| Jun 2016 | - | -$4.38 M(-20.4%) |
| Mar 2016 | - | -$5.50 M(+26.5%) |
| Dec 2015 | -$4.35 M(-77.9%) | -$4.35 M(-39.8%) |
| Sep 2015 | - | -$7.23 M(-38.7%) |
| Jun 2015 | - | -$11.79 M(-23.3%) |
| Mar 2015 | - | -$15.36 M(-22.1%) |
| Dec 2014 | -$19.73 M(-59.3%) | -$19.73 M(-51.6%) |
| Sep 2014 | - | -$40.73 M(-14.2%) |
| Jun 2014 | - | -$47.48 M(+5.2%) |
| Mar 2014 | - | -$45.11 M(-6.9%) |
| Dec 2013 | -$48.47 M(-80.2%) | -$48.47 M(-6.6%) |
| Sep 2013 | - | -$51.90 M(-2.2%) |
| Jun 2013 | - | -$53.10 M(-78.5%) |
| Mar 2013 | - | -$247.25 M(+0.9%) |
| Dec 2012 | -$244.96 M | -$244.96 M(+1.7%) |
| Sep 2012 | - | -$240.97 M(+2.6%) |
| Jun 2012 | - | -$234.85 M(+3.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | -$227.50 M(+4.7%) |
| Dec 2011 | -$217.24 M(+31.2%) | -$217.24 M(+3.2%) |
| Sep 2011 | - | -$210.59 M(+6.4%) |
| Jun 2011 | - | -$197.86 M(+8.2%) |
| Mar 2011 | - | -$182.88 M(+10.4%) |
| Dec 2010 | -$165.63 M(+38.7%) | -$165.63 M(+8.7%) |
| Sep 2010 | - | -$152.36 M(+8.2%) |
| Jun 2010 | - | -$140.77 M(+8.3%) |
| Mar 2010 | - | -$129.97 M(+8.8%) |
| Dec 2009 | -$119.43 M(+66.1%) | -$119.43 M(+37.4%) |
| Sep 2009 | - | -$86.95 M(+7.9%) |
| Jun 2009 | - | -$80.58 M(+6.1%) |
| Mar 2009 | - | -$75.96 M(+5.6%) |
| Dec 2008 | -$71.91 M(+32.0%) | -$71.91 M(+1.6%) |
| Sep 2008 | - | -$70.74 M(+10.3%) |
| Jun 2008 | - | -$64.16 M(+10.4%) |
| Mar 2008 | - | -$58.11 M(+6.7%) |
| Dec 2007 | -$54.48 M(+16.2%) | -$54.48 M(+3.2%) |
| Sep 2007 | - | -$52.81 M(+3.3%) |
| Jun 2007 | - | -$51.11 M(+4.9%) |
| Mar 2007 | - | -$48.71 M(+3.9%) |
| Dec 2006 | -$46.90 M(-5.6%) | -$46.90 M(-16.1%) |
| Sep 2006 | - | -$55.89 M(+1.4%) |
| Jun 2006 | - | -$55.14 M(+4.2%) |
| Mar 2006 | - | -$52.92 M(+6.5%) |
| Dec 2005 | -$49.69 M(+22.6%) | -$49.69 M(+4.7%) |
| Sep 2005 | - | -$47.48 M(+4.6%) |
| Jun 2005 | - | -$45.39 M(+6.0%) |
| Mar 2005 | - | -$42.81 M(+5.6%) |
| Dec 2004 | -$40.54 M(+44.7%) | -$40.54 M(+12.9%) |
| Sep 2004 | - | -$35.91 M(+8.7%) |
| Jun 2004 | - | -$33.04 M(+8.4%) |
| Mar 2004 | - | -$30.47 M(+8.7%) |
| Dec 2003 | -$28.02 M(+27.0%) | -$28.02 M(+6.3%) |
| Sep 2003 | - | -$26.36 M(+5.8%) |
| Jun 2003 | - | -$24.92 M(+6.9%) |
| Mar 2003 | - | -$23.31 M(+5.6%) |
| Dec 2002 | -$22.06 M(+20.9%) | -$22.06 M(+1.9%) |
| Sep 2002 | - | -$21.65 M(+3.8%) |
| Jun 2002 | - | -$20.85 M(+7.7%) |
| Mar 2002 | - | -$19.35 M(+6.0%) |
| Dec 2001 | -$18.25 M(+16.7%) | -$18.25 M(+8.4%) |
| Sep 2001 | - | -$16.84 M(-2.0%) |
| Jun 2001 | - | -$17.19 M(+5.3%) |
| Mar 2001 | - | -$16.33 M(+4.4%) |
| Dec 2000 | -$15.64 M(+28.2%) | -$15.64 M(+6.3%) |
| Sep 2000 | - | -$14.71 M(+4.4%) |
| Jun 2000 | - | -$14.09 M(+11.3%) |
| Mar 2000 | - | -$12.66 M |
| Dec 1999 | -$12.20 M(+13.0%) | - |
| Dec 1998 | -$10.80 M | - |
FAQ
- What is ANI Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual retained earnings year-on-year change?
- What is ANI Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly retained earnings year-on-year change?
What is ANI Pharmaceuticals annual retained earnings?
The current annual retained earnings of ANIP is -$80.13 M
What is the all time high annual retained earnings for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual retained earnings is $17.58 M
What is ANI Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, ANIP annual retained earnings has changed by +$17.15 M (+17.63%)
What is ANI Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of ANIP is -$89.60 M
What is the all time high quarterly retained earnings for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly retained earnings is $22.42 M
What is ANI Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, ANIP quarterly retained earnings has changed by -$8.72 M (-10.78%)